Join us in Beijing to Counter Antimicrobial Resistance

Register now for the May 2018 Nature conference on Countering Antimicrobial Resistance and join the fight to beat back the bad bugs

Like Comment

One of the most exciting and rewarding* parts of being an editor at a Nature journal is the chance to work with colleagues and the research community to put together conferences dedicated to certain parts of the field, or aligned with particular topical themes. And at the present time in microbiology, medicine and public health, there are few topics more timely and relevant than the potential threats posed by the spread of antimicrobial resistance and the faltering of our drug and vaccine development pipelines.

While occasional doom-laden headlines can sometimes err of the side of hyperbole (and some are down-right hysterical), the problems faced in controlling and treating drug resistant infections are very real, and look set to worsen in years to come. Resistant microorganisms will affect many of those reading this piece directly, or indirectly through infection of family members, friends and colleagues. Being a microbiologist (or microbiology editor**) will provide irony not immunity when drug-resistant infection comes calling.

So what can we do to try and help push back against resistance, even slightly? Well as an editor I can publishing exciting new avenues of research in the discovery and development of antimicrobial approaches, and use Nature Microbiology’s editorial voice to raise awareness of resistance and encourage, of course. But when trying to effect change, one of the best ways is often to get a bunch of smart people together in a room for a proper assessment of the problems faced and to catalyse the development of potential solutions.

That is why I have been thrilled to work with colleagues from Nature Microbiology, Nature Biotechnology, Nature Medicine and Sichuan University, China to pull together the upcoming Nature conference on Countering Antimicrobial Resistance, May 28-29th 2018 in Beijing, China. We have a fantastic line up of speakers with diverse expertise from the basic research laboratory, industry and public health bodies and are going to be looking at the issues surrounding antimicrobial resistance from many angles.

Genuinely I have not looked forward to attending a conference quite so much for some time, and I do hope that I might get a chance to meet some of you in Beijing in May.

The conference website is here:

And you can register now here:


Our speakers:

Chase Beisel (Helmholtz Institute for RNA-based Infection Research, Germany)

Sean Brady (The Rockefeller University, USA)

Ilana Brito (MIT, USA)

Eric Brown (McMaster University, Canada)

Gautam Dantas (Washington University, USA)

Herman Goossens (University of Antwerp, Belgium)

Christina Vandenbroucke-Grauls (VU Medical Center Amsterdam, Netherlands)

Kat Holt (University of Melbourne, Australia)

Jian-Dong Jiang (China Academy of Medical Sciences, China)

Jennifer Leeds (Novartis, USA)

Max Nieuwdorp (University of Amsterdam, The Netherlands)

Kevin Outterson (Boston University, USA)

Sharon Peacock (University of Cambridge, UK)

Xiao-Qing Qiu (Sichuan University, China)

Jean-Marie Pages (Aix-Marseille Université, France)

Rino Rappuoli (GlaxoSmithKline, Italy)

John Rex (F2G Limited, UK)

Margaret Riley (University of Massachusetts Amherst, USA)

Tanja Schneider (University of Bonn, Germany)

Eriko Takano (University of Manchester, UK)

Nick Thomson (University of Cambridge, UK)

Tim Walsh (Cardiff University, UK)

Yu Wang (Chinese Center for Disease Control and Prevention, China)

Younghui Zhang (Huazhong University of Science and Technology, China)



*Experientially rewarding, alas not financially so, despite the additional work required.

**Yes, even microbiology editors and their families have their troubles with antibiotic resistant bacteria on occasion

Andrew Jermy

Consultant, Germinate

Andrew gained his PhD in Molecular Biology from the University of Manchester, UK, studying fungal protein trafficking and secretion. He was subsequently a microbiology editor at Nature for more than a decade, joining Nature Reviews Microbiology in 2008 as an Associate Editor after a brief stint as locum editor on Nature Cell Biology. Over the following 4.5 years Andrew developed a passion for the field, commissioning Reviews and writing on all aspects of microbiology. He also took a keen interest in developing new approaches to communicate with the microbiology community. In January 2013 Andrew joined the Nature team as Senior Editor, handling primary manuscripts from across the field and championing microbiology in Nature’s pages and beyond. Andrew left Nature in April 2015 to become the Chief Editor for the launch of Nature Microbiology. Having helped to establish Nature Microbiology as one of the premier journals in the microbiology publishing landscape, and in search of a better work-life balance, in January 2019 he left Nature to become Chief Publishing Officer (and tea boy) for the family GCSE and A-Level educational resources business established by his wife over the preceding three years.